MMP2 and metastatic neoplasm: They discovered that miR-1233-3p was a target of circEHMT1 and showed that circEHMT1 could regulate MMP2 (matrix metallopeptidase 2), which is upregulated at sites of tissue damage, inflammation, and in stromal cells surrounding the invading front of metastatic tumors.